Toll Free: 1-888-928-9744
Published: Nov, 2014 | Pages:
35 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
IMPACT Therapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'IMPACT Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the IMPACT Therapeutics, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of IMPACT Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of IMPACT Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of IMPACT Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the IMPACT Therapeutics, Inc.'s pipeline products Reasons to buy - Evaluate IMPACT Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of IMPACT Therapeutics, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the IMPACT Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of IMPACT Therapeutics, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of IMPACT Therapeutics, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of IMPACT Therapeutics, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 IMPACT Therapeutics, Inc. Snapshot 5 IMPACT Therapeutics, Inc. Overview 5 Key Information 5 Key Facts 5 IMPACT Therapeutics, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 IMPACT Therapeutics, Inc. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 IMPACT Therapeutics, Inc. - Pipeline Products Glance 11 IMPACT Therapeutics, Inc. - Early Stage Pipeline Products 11 Preclinical Products/Combination Treatment Modalities 11 Discovery Products/Combination Treatment Modalities 12 IMPACT Therapeutics, Inc. - Drug Profiles 13 IMP-03138 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 IMP-04149 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 IMP-04297 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 IMP-05364 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 IMP-05403 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Small Molecules to Inhibit Hedgehog Pathway for Oncology 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 IMP-04100 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 IMP-04111 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 IMP-04249 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 IMP-04307 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 IMP-04356 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 IMP-05361 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 IMP-05367 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 IMP-05369 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 IMP-05379 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 IMPACT Therapeutics, Inc. - Pipeline Analysis 28 IMPACT Therapeutics, Inc. - Pipeline Products by Target 28 IMPACT Therapeutics, Inc. - Pipeline Products by Route of Administration 29 IMPACT Therapeutics, Inc. - Pipeline Products by Molecule Type 30 IMPACT Therapeutics, Inc. - Pipeline Products by Mechanism of Action 31 IMPACT Therapeutics, Inc. - Dormant Projects 32 IMPACT Therapeutics, Inc. - Locations And Subsidiaries 33 Head Office 33 Appendix 34 Methodology 34 Coverage 34 Secondary Research 34 Primary Research 34 Expert Panel Validation 34 Contact Us 35 Disclaimer 35
List of Tables IMPACT Therapeutics, Inc., Key Information 5 IMPACT Therapeutics, Inc., Key Facts 5 IMPACT Therapeutics, Inc. - Pipeline by Indication, 2014 8 IMPACT Therapeutics, Inc. - Pipeline by Stage of Development, 2014 9 IMPACT Therapeutics, Inc. - Monotherapy Products in Pipeline, 2014 10 IMPACT Therapeutics, Inc. - Preclinical, 2014 11 IMPACT Therapeutics, Inc. - Discovery, 2014 12 IMPACT Therapeutics, Inc. - Pipeline by Target, 2014 28 IMPACT Therapeutics, Inc. - Pipeline by Route of Administration, 2014 29 IMPACT Therapeutics, Inc. - Pipeline by Molecule Type, 2014 30 IMPACT Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2014 31 IMPACT Therapeutics, Inc. - Dormant Developmental Projects,2014 32
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.